287 related articles for article (PubMed ID: 38178125)
1. Uptake of intermittent preventive treatment of malaria in pregnancy and risk factors for maternal anaemia and low birthweight among HIV-negative mothers in Dschang, West region of Cameroon: a cross sectional study.
Kamga SLS; Ali IM; Ngangnang GR; Ulucesme MC; Keptcheu LTD; Keming EM; Tchuenkam VK; Foyet JV; Aktas M; Noubom M; Payne VK
Malar J; 2024 Jan; 23(1):6. PubMed ID: 38178125
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
[TBL] [Abstract][Full Text] [Related]
4. Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.
Mikomangwa WP; Oms M; Aklillu E; Kamuhabwa AAR
BMC Pregnancy Childbirth; 2019 Jul; 19(1):236. PubMed ID: 31286878
[TBL] [Abstract][Full Text] [Related]
5. Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.
Anchang-Kimbi JK; Kalaji LN; Mbacham HF; Wepnje GB; Apinjoh TO; Ngole Sumbele IU; Dionne-Odom J; Tita ATN; Achidi EA
Malar J; 2020 Mar; 19(1):100. PubMed ID: 32122339
[TBL] [Abstract][Full Text] [Related]
6. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011444. PubMed ID: 30480761
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
Mosha D; Chilongola J; Ndeserua R; Mwingira F; Genton B
Trop Med Int Health; 2014 Sep; 19(9):1048-56. PubMed ID: 24965022
[TBL] [Abstract][Full Text] [Related]
8. Intermittent preventive treatment with Sulphadoxine-Pyrimethamine (IPTp-SP) is associated with protection against sub-microscopic P. falciparum infection in pregnant women during the low transmission dry season in southwestern Cameroon: A Semi - longitudinal study.
Apinjoh TO; Ntui VN; Chi HF; Moyeh MN; Toussi CT; Mayaba JM; Tangi LN; Kwi PN; Anchang-Kimbi JK; Dionne-Odom J; Tita ATN; Achidi EA; Amambua-Ngwa A; Titanji VPK
PLoS One; 2022; 17(9):e0275370. PubMed ID: 36178962
[TBL] [Abstract][Full Text] [Related]
9. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
Mikomangwa WP; Minzi O; Mutagonda R; Baraka V; Mlugu EM; Aklillu E; Kamuhabwa AAR
Malar J; 2020 Apr; 19(1):160. PubMed ID: 32306955
[TBL] [Abstract][Full Text] [Related]
10. The positive effect of malaria IPTp-SP on birthweight is mediated by gestational weight gain but modifiable by maternal carriage of enteric pathogens.
Waltmann A; McQuade ETR; Chinkhumba J; Operario DJ; Mzembe E; Itoh M; Kayange M; Puerto-Meredith SM; Mathanga DP; Juliano JJ; Carroll I; Bartelt LA; Gutman JR; Meshnick SR
EBioMedicine; 2022 Mar; 77():103871. PubMed ID: 35217408
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi.
Verhoeff FH; Brabin BJ; Chimsuku L; Kazembe P; Russell WB; Broadhead RL
Ann Trop Med Parasitol; 1998 Mar; 92(2):141-50. PubMed ID: 9625909
[TBL] [Abstract][Full Text] [Related]
12. Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
Bouyou-Akotet MK; Mawili-Mboumba DP; Kendjo E; Moutandou Chiesa S; Tshibola Mbuyi ML; Tsoumbou-Bakana G; Zong J; Ambounda N; Kombila M
Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):333-42. PubMed ID: 27268713
[TBL] [Abstract][Full Text] [Related]
13. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
Walker PG; Floyd J; Ter Kuile F; Cairns M
PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259
[TBL] [Abstract][Full Text] [Related]
14. Malaria risk factors in women on intermittent preventive treatment at delivery and their effects on pregnancy outcome in Sanaga-Maritime, Cameroon.
Tonga C; Kimbi HK; Anchang-Kimbi JK; Nyabeyeu HN; Bissemou ZB; Lehman LG
PLoS One; 2013; 8(6):e65876. PubMed ID: 23762446
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi.
Gutman J; Mwandama D; Wiegand RE; Ali D; Mathanga DP; Skarbinski J
J Infect Dis; 2013 Sep; 208(6):907-16. PubMed ID: 23801600
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for placental malaria and associated adverse pregnancy outcomes in Rufiji, Tanzania: a hospital based cross sectional study.
Ndeserua R; Juma A; Mosha D; Chilongola J
Afr Health Sci; 2015 Sep; 15(3):810-8. PubMed ID: 26957969
[TBL] [Abstract][Full Text] [Related]
17. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
[TBL] [Abstract][Full Text] [Related]
18. Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique.
Arnaldo P; Rovira-Vallbona E; Langa JS; Salvador C; Guetens P; Chiheb D; Xavier B; Kestens L; Enosse SM; Rosanas-Urgell A
Malar J; 2018 Mar; 17(1):109. PubMed ID: 29530044
[TBL] [Abstract][Full Text] [Related]
19. High uptake of Intermittent Preventive Treatment of malaria in pregnancy is associated with improved birth weight among pregnant women in Ghana.
Quakyi I; Tornyigah B; Houze P; Kusi KA; Coleman N; Escriou G; Laar A; Cot M; Fobil J; Asare GQ; Deloron P; Anang AK; Cottrell G; Ofori MF; Ndam NT
Sci Rep; 2019 Dec; 9(1):19034. PubMed ID: 31836735
[TBL] [Abstract][Full Text] [Related]
20. Effect of group versus individual antenatal care on uptake of intermittent prophylactic treatment of malaria in pregnancy and related malaria outcomes in Nigeria and Kenya: analysis of data from a pragmatic cluster randomized trial.
Noguchi L; Grenier L; Kabue M; Ugwa E; Oyetunji J; Suhowatsky S; Onguti B; Orji B; Whiting-Collins L; Adetiloye O
Malar J; 2020 Jan; 19(1):51. PubMed ID: 31996209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]